Campylobacter jejuniinfections and anti-GM1 antibodies in guillain-barré syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Campylobacter jejuniinfections and anti-GM1 antibodies in guillain-barré syndrome

Published:1996-08 Issue:2 Volume:40 Page:181-187
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Jacobs Bart C.,van Doorn Pieter A.,Tio-Gillen Anne P.,Visser Leo H.,van der Meché Frans G. A.,Schmitz Paul I. M.,Herbrink Paul,Hooijkaas Herbert

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference37 articles.

1. Assessment of current diagnostic criteria for Guillain-Barré syndrome;Asbury;Ann Neurol,1990

2. Patterns of conduction failure in the Guillain-Barré syndrome;Van der Meché;Brain,1988

3. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies;Van der Meché;Ann Neurol,1995

4. Guillain-Barré syndrome and Campylobacter jejuni: a serological study;Kaldor;Br Med J,1984

5. A prospective study of acute idiopathic neuropathy II. Antecedent event;Winer;J Neurol Neurosurg Psychiatry,1988

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Comprehensive Microbiological and Metagenomic Analysis of the Guillain–Barré Syndrome Outbreak in Lima, 2019;Microbiology Research;2024-09-08

3. Efficacy and safety of eculizumab in Guillain‐Barré syndrome: A phase 3, multicenter, double‐blind, randomized, placebo‐controlled clinical trial;Journal of the Peripheral Nervous System;2024-07-10

4. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial;Restorative Neurology and Neuroscience;2024-02-15

5. An updated review on Guillain-Barré syndrome: Challenges in infection prevention and control in low- and middle-income countries;SAGE Open Medicine;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3